Metabolic syndrome dietary therapy: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(23 intermediate revisions by 9 users not shown)
Line 1: Line 1:
__NOTOC__
{{Metabolic syndrome}}
{{Metabolic syndrome}}
 
{{CMG}}; {{AE}} [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh13579@gmail.com]
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.B.B.S.]] [mailto:psingh@perfuse.org]


==Overview==
==Overview==
Dietary modifications are the first step in treatment of metabolic syndrome. It can be started in isolation or along with other medications. It helps by assisting in weight loss, thus increasing insulin sensitivity. Studies support that diet, exercise, and drug therapy may inhibit the progression of metabolic syndrome to diabetes mellitus.
Dietary modifications are the first step in the management of metabolic syndrome. It can be initiated either in isolation or along with other medications. It helps by assisting in [[weight loss]], thus increasing [[insulin sensitivity]]. Studies support that [[diet]], [[exercise]], and [[drug therapy]] may inhibit the progression of metabolic syndrome to [[diabetes mellitus]].<ref name="pmid19776619">{{cite journal |author=Levesque J, Lamarche B |title=The metabolic syndrome: definitions, prevalence and management |journal=[[Journal of Nutrigenetics and Nutrigenomics]] |volume=1 |issue=3 |pages=100–8 |year=2008 |pmid=19776619 |doi=10.1159/000112457 |url=}}</ref>


==Dietary modifications==
==Dietary Therapy==
Findings from various studies suggest that:
Findings from various studies suggest that:<ref name="pmid18971485">{{cite journal |author=Cornier MA, Dabelea D, Hernandez TL, ''et al.'' |title=The metabolic syndrome |journal=Endocrine Reviews |volume=29 |issue=7 |pages=777–822 |year=2008 |month=December |pmid=18971485 |doi=10.1210/er.2008-0024 |url=}}</ref>
* Westernized and high [[fructose]] diets have increased risk for developing metabolic syndrome.
* Mediterranean diet rich in fresh fruits, vegetables, whole grains, nuts, seeds, legumes, seafood, yogurt and olive oil lowers the risks for metabolic syndrome.<ref name="pmid21387364">{{cite journal| author=Barnes DE| title=The mediterranean diet: good for the heart = good for the brain? | journal=Ann Neurol | year= 2011 | volume= 69 | issue= 2 | pages= 226-8 | pmid=21387364 | doi=10.1002/ana.22376 | pmc= | url= }} </ref><ref name="pmid21392646">{{cite journal| author=Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB| title=The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. | journal=J Am Coll Cardiol | year= 2011 | volume= 57 | issue= 11 | pages= 1299-313 | pmid=21392646 | doi=10.1016/j.jacc.2010.09.073 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21392646  }} </ref><ref name="pmid19064829">{{cite journal| author=Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-González MA, Fitó M, Estruch R et al.| title=Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. | journal=Arch Intern Med | year= 2008 | volume= 168 | issue= 22 | pages= 2449-58 | pmid=19064829 | doi=10.1001/archinte.168.22.2449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19064829  }} </ref>
* The [[DASH]] ([[Dietary Approaches to Stop Hypertension]]) diet focuses on decreasing [[sodium]] intake to 2400 mg/daily. When compared to a weight reducing diet, the [[DASH diet|DASH]] diet resulted in greater improvements in [[triglycerides]], [[blood pressure]], and [[fasting blood glucose]].<ref name="pmid16306540">{{cite journal| author=Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F| title=Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. | journal=Diabetes Care | year= 2005 | volume= 28 | issue= 12 | pages= 2823-31 | pmid=16306540 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16306540  }} </ref>
* A low [[carbohydrate]] diet has favorable effects on atherogenic [[dyslipidemia]] and [[glycemic control]] compared to a conventional diet at 6 months, but there does not appear to be a significant benefit at 1 year.<ref name="pmid12761365">{{cite journal| author=Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS et al.| title=A randomized trial of a low-carbohydrate diet for obesity. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 21 | pages= 2082-90 | pmid=12761365 | doi=10.1056/NEJMoa022207 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12761365  }} </ref><ref name="pmid15148064">{{cite journal| author=Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J et al.| title=The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. | journal=Ann Intern Med | year= 2004 | volume= 140 | issue= 10 | pages= 778-85 | pmid=15148064 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15148064  }} </ref><ref name="pmid17622289">{{cite journal| author=Meckling KA, Sherfey R| title=A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women. | journal=Appl Physiol Nutr Metab | year= 2007 | volume= 32 | issue= 4 | pages= 743-52 | pmid=17622289 | doi=10.1139/H07-059 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17622289  }} </ref> However, the supporting studies are small randomized trials (less than 150 patients). Thus, larger studies are required to determine the long-term safety and efficacy of low-[[carbohydrate]], high-[[protein]], high-fat diets.
* Some studies suggest that moderate red wine intake may protect against the development of metabolic syndrome.<ref name="pmid18537695">{{cite journal| author=Liu L, Wang Y, Lam KS, Xu A| title=Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications. | journal=Endocr Metab Immune Disord Drug Targets | year= 2008 | volume= 8 | issue= 2 | pages= 89-98 | pmid=18537695 | doi= | pmc= | url= }} </ref> However, further supportive evidence is required.
* In a [[meta-analysis]] chocolate was found to reduce the risks of [[coronary artery disease]], cardiac deaths, [[diabetes]], and [[stroke]] by approximately 30%. The possible explanation for this is the presence of [[polyphenols]] in chocolates that increases the concentration of [[nitric oxide]] ([[antioxidants]]).<ref name="pmid21875885">{{cite journal| author=Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E et al.| title=Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. | journal=BMJ | year= 2011 | volume= 343 | issue=  | pages= d4488 | pmid=21875885 | doi=10.1136/bmj.d4488 | pmc=PMC3163382 | url= }} </ref>
* Food with a low [[glycemic index]] may be helpful in preventing [[metabolic syndrome]] and its complications. However, further supportive trials are required to prove this.


* Westernized and high fructose diets have increased risk for developing metabolic syndrome.
==Supportive Trial Data==
===Meta-analysis on effect of Mediterranean diet on metabolic syndrome===


* Mediterranean diet rich in fresh fruits, vegetables, whole grains, nuts, seeds, legumes, seafood, yogurt and olive oil lowers the risks for metabolic syndrome <ref name="pmid21387364">{{cite journal| author=Barnes DE| title=The mediterranean diet: good for the heart = good for the brain? | journal=Ann Neurol | year= 2011 | volume= 69 | issue= 2 | pages= 226-8 | pmid=21387364 | doi=10.1002/ana.22376 | pmc= | url= }} </ref>, <ref name="pmid21392646">{{cite journal| author=Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB| title=The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. | journal=J Am Coll Cardiol | year= 2011 | volume= 57 | issue= 11 | pages= 1299-313 | pmid=21392646 | doi=10.1016/j.jacc.2010.09.073 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21392646  }} </ref>, <ref name="pmid19064829">{{cite journal| author=Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-González MA, Fitó M, Estruch R et al.| title=Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. | journal=Arch Intern Med | year= 2008 | volume= 168 | issue= 22 | pages= 2449-58 | pmid=19064829 | doi=10.1001/archinte.168.22.2449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19064829  }} </ref>.
* SOURCE and YEAR: J Am Coll Cardiol, 2011<ref name="pmid21392646">{{cite journal| author=Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB| title=The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. | journal=J Am Coll Cardiol | year= 2011 | volume= 57 | issue= 11 | pages= 1299-313 | pmid=21392646 | doi=10.1016/j.jacc.2010.09.073 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21392646  }} </ref>


* The [[DASH]] ([[Dietary Approaches to Stop Hypertension]]) diet focusing on decreased [[sodium]] intake to 2400 mg/daily, when compared to a weight reducing diet, resulted in greater improvements in [[triglycerides]], [[blood pressure]], and [[fasting blood glucose]] <ref name="pmid16306540">{{cite journal| author=Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F| title=Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. | journal=Diabetes Care | year= 2005 | volume= 28 | issue= 12 | pages= 2823-31 | pmid=16306540 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16306540  }} </ref>.
* OBJECTIVE: Effect of a Mediterranean diet on [[metabolic syndrome]] and its components.  


* Low carbohydrate diet has favorable effects on atherogenic dyslipidemia and glycemic control compared to a conventional diet at 6 months of follow up but no significant benefit at 1year was seen <ref name="pmid12761365">{{cite journal| author=Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS et al.| title=A randomized trial of a low-carbohydrate diet for obesity. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 21 | pages= 2082-90 | pmid=12761365 | doi=10.1056/NEJMoa022207 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12761365  }} </ref>, <ref name="pmid15148064">{{cite journal| author=Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J et al.| title=The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial. | journal=Ann Intern Med | year= 2004 | volume= 140 | issue= 10 | pages= 778-85 | pmid=15148064 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15148064  }} </ref>, <ref name="pmid12761365">{{cite journal| author=Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS et al.| title=A randomized trial of a low-carbohydrate diet for obesity. | journal=N Engl J Med | year= 2003 | volume= 348 | issue= 21 | pages= 2082-90 | pmid=12761365 | doi=10.1056/NEJMoa022207 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12761365  }} </ref>, <ref name="pmid17622289">{{cite journal| author=Meckling KA, Sherfey R| title=A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women. | journal=Appl Physiol Nutr Metab | year= 2007 | volume= 32 | issue= 4 | pages= 743-52 | pmid=17622289 | doi=10.1139/H07-059 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17622289  }} </ref>. However, the supporting studies are small randomized trials (less than 150 patients). Thus, larger studies are required to determine the long-term safety and efficacy of low-carbohydrate, high-protein, high-fat diets.
* METHOD: [[Meta-analysis]]


* Some studies suggest that moderate red wine intake may protect against the development of metabolic syndrome <ref name="pmid18537695">{{cite journal| author=Liu L, Wang Y, Lam KS, Xu A| title=Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications. | journal=Endocr Metab Immune Disord Drug Targets | year= 2008 | volume= 8 | issue= 2 | pages= 89-98 | pmid=18537695 | doi= | pmc= | url= }} </ref>. However, further supportive evidences are required.
* STUDY POPULATION: 50 original research studies (35 clinical trials, 2 prospective and 13 cross-sectional), with 534,906 participants


* Interestingly, in a meta-analysis chocolate was found to reduce the risks of [[coronary artery disease]], [[cardiac deaths]], [[diabetes]], and [[stroke]] by approximately 30%. The possible explanation for this is the presence of [[polyphenols]] in chocolates that increases the concentration of [[nitric oxide]] ([[antioxidants]]) <ref name="pmid21875885">{{cite journal| author=Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E et al.| title=Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. | journal=BMJ | year= 2011 | volume= 343 | issue=  | pages= d4488 | pmid=21875885 | doi=10.1136/bmj.d4488 | pmc=PMC3163382 | url= }} </ref>.
* RESULTS:
** Mediterranean diet was associated with reduced risk of metabolic syndrome (log hazard ratio: -0.69, 95% confidence interval [CI]: -1.24 to -1.16)
** Also, statistically significant reduction in waist circumference, [[triglycerides]], [[systolic]] and [[diastolic]] [[blood pressure]] and [[glucose]] was found. Additionally,  an elevation of [[HDL]] cholesterol level was demonstrated.


* Food with low [[glycemic index]] may be helpful in preventing [[metabolic syndrome]] and its complications. However, further supportive trials are required to prove this.
===PREDIMED: Randomized controlled trial on effect of Mediterranean diet on metabolic syndrome===


==Trial supportive data==
*  SOURCE and YEAR: Arch Intern Med. 2008<ref name="pmid19064829">{{cite journal| author=Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-González MA, Fitó M, Estruch R et al.| title=Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. | journal=Arch Intern Med | year= 2008 | volume= 168 | issue= 22 | pages= 2449-58 | pmid=19064829 | doi=10.1001/archinte.168.22.2449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19064829  }} </ref>


===Meta-analysis on effect of Mediterranean diet on metabolic syndrome <ref name="pmid21392646">{{cite journal| author=Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB| title=The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. | journal=J Am Coll Cardiol | year= 2011 | volume= 57 | issue= 11 | pages= 1299-313 | pmid=21392646 | doi=10.1016/j.jacc.2010.09.073 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21392646  }} </ref>===
* STUDY NAME: PREDIMED (Prevención con Dieta Mediterránea)


* '''Source & year''' - J Am Coll Cardiol, 2011
* OBJECTIVE: Determine the efficacy of the [[Mediterranean diet|Mediterranean die]]<nowiki/>t (Med-Diet) on the primary prevention of cardiovascular disease


* '''Study question''' - Effect of a Mediterranean diet on [[metabolic syndrome]] and its components.  
* METHOD: Multicenter, 3-arm randomized controlled trial.


* '''Study design''' – [[Meta-analysis]]
* STUDY POPULATION: 1224 participants


* '''Study Population''' - {50 original research studies (35 clinical trials, 2 prospective and 13 cross-sectional), with 534,906 participants}
* STUDY PERIOD: 1 year


* '''Study results''' -
* INTERVENTIONS: Quarterly education about the MedDiet + provision of either 1 L/wk of virgin olive oil or 30 g/d of mixed nuts, and advice on a low-fat diet (control diet).
* Mediterranean diet was associated with reduced risk of metabolic syndrome (log hazard ratio: -0.69, 95% confidence interval [CI]: -1.24 to -1.16)


* Also, statistically significant reduction in waist circumference, [[triglycerides]], systolic and diastolic [[blood pressure]] and [[glucose]] was found. Additionally,  an elevation of [[HDL]] cholesterol level was demonstrated.
* RESULTS:
 
** 61.4% of participants met criteria for the [[metabolic syndrome]]
===PREDIMED: Randomized controlled trial on effect of Mediterranean diet on metabolic syndrome <ref name="pmid19064829">{{cite journal| author=Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-González MA, Fitó M, Estruch R et al.| title=Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial. | journal=Arch Intern Med | year= 2008 | volume= 168 | issue= 22 | pages= 2449-58 | pmid=19064829 | doi=10.1001/archinte.168.22.2449 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19064829  }} </ref>===
 
* '''Source & year''' - Arch Intern Med. 2008
 
* '''Study name''' - PREDIMED (Prevención con Dieta Mediterránea)
 
* '''Study question''' – Determine the efficacy of the Mediterranean diet (Med-Diet) on the primary prevention of cardiovascular disease
 
* '''Study design''' – Multicenter, 3-arm randomized controlled trial.
 
* '''Study Population''' – 1224 participant
 
* '''Study period''' – 1 year
 
* '''Interventions''' - Quarterly education about the MedDiet + provision of either 1 L/wk of virgin olive oil or 30 g/d of mixed nuts, and advice on a low-fat diet (control diet).
 
* '''Study results''' –
 
* 61.4% of participants met criteria for the [[metabolic syndrome]]
** 1 yr prevalence was reduced by 6.7%, 13.7%, and 2.0% in the MedDiet + virgin olive oil, MedDiet + nuts, and control diet groups, respectively  
** 1 yr prevalence was reduced by 6.7%, 13.7%, and 2.0% in the MedDiet + virgin olive oil, MedDiet + nuts, and control diet groups, respectively  
* After adjustment for sex, age, baseline obesity status, and weight changes odds ratios for reversion of metabolic syndrome were  
** After adjustment for sex, age, baseline obesity status, and weight changes odds ratios for reversion of metabolic syndrome were:
** 1.3 (95% confidence interval, 0.8-2.1) for the MedDiet + virgin olive oil compared with control group.
*** 1.3 (95% confidence interval, 0.8-2.1) for the MedDiet + virgin olive oil compared with control group.
** 1.7 (1.1-2.6) for the MedDiet + nuts group compared with control group.
*** 1.7 (1.1-2.6) for the MedDiet + nuts group compared with control group.
 
'''*''' '''Study conclusion''' - Mediterranean diet can be helpful in management of metabolic syndrome.


==See also==
* CONCLUSION: A [[Mediterranean diet|Mediterranean]] diet can be helpful in the management of metabolic syndrome.
* [[Hyperinsulinemia]]
* [[Insulin resistance]]
* [[Chronic Somogyi rebound]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WS}}
{{WH}}


[[Category:Cardiology]]
[[Category:Cardiology]]
[[Category:Endocrinology]]
[[Category:Endocrinology]]
[[Category:Genetic disorders]]
[[Category:Metabolic disorders]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Overview complete]]
[[Category:Template complete]]
[[Category:Medical conditions related to obesity]]
[[Category:Syndromes]]
[[Category: Up-To-Date]]
[[Category: Up-To-Date Cardiology]]
{{WS}}
{{WH}}

Latest revision as of 21:47, 16 October 2017

Metabolic syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Metabolic Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Dietary Therapy

Physical Activity

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Metabolic syndrome dietary therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Metabolic syndrome dietary therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Metabolic syndrome dietary therapy

CDC on Metabolic syndrome dietary therapy

Metabolic syndrome dietary therapy in the news

Blogs on Metabolic syndrome dietary therapy

Directions to Hospitals Treating Metabolic syndrome

Risk calculators and risk factors for Metabolic syndrome dietary therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

Dietary modifications are the first step in the management of metabolic syndrome. It can be initiated either in isolation or along with other medications. It helps by assisting in weight loss, thus increasing insulin sensitivity. Studies support that diet, exercise, and drug therapy may inhibit the progression of metabolic syndrome to diabetes mellitus.[1]

Dietary Therapy

Findings from various studies suggest that:[2]

  • Westernized and high fructose diets have increased risk for developing metabolic syndrome.
  • Mediterranean diet rich in fresh fruits, vegetables, whole grains, nuts, seeds, legumes, seafood, yogurt and olive oil lowers the risks for metabolic syndrome.[3][4][5]
  • The DASH (Dietary Approaches to Stop Hypertension) diet focuses on decreasing sodium intake to 2400 mg/daily. When compared to a weight reducing diet, the DASH diet resulted in greater improvements in triglycerides, blood pressure, and fasting blood glucose.[6]
  • A low carbohydrate diet has favorable effects on atherogenic dyslipidemia and glycemic control compared to a conventional diet at 6 months, but there does not appear to be a significant benefit at 1 year.[7][8][9] However, the supporting studies are small randomized trials (less than 150 patients). Thus, larger studies are required to determine the long-term safety and efficacy of low-carbohydrate, high-protein, high-fat diets.
  • Some studies suggest that moderate red wine intake may protect against the development of metabolic syndrome.[10] However, further supportive evidence is required.
  • In a meta-analysis chocolate was found to reduce the risks of coronary artery disease, cardiac deaths, diabetes, and stroke by approximately 30%. The possible explanation for this is the presence of polyphenols in chocolates that increases the concentration of nitric oxide (antioxidants).[11]
  • Food with a low glycemic index may be helpful in preventing metabolic syndrome and its complications. However, further supportive trials are required to prove this.

Supportive Trial Data

Meta-analysis on effect of Mediterranean diet on metabolic syndrome

  • SOURCE and YEAR: J Am Coll Cardiol, 2011[4]
  • STUDY POPULATION: 50 original research studies (35 clinical trials, 2 prospective and 13 cross-sectional), with 534,906 participants
  • RESULTS:
    • Mediterranean diet was associated with reduced risk of metabolic syndrome (log hazard ratio: -0.69, 95% confidence interval [CI]: -1.24 to -1.16)
    • Also, statistically significant reduction in waist circumference, triglycerides, systolic and diastolic blood pressure and glucose was found. Additionally, an elevation of HDL cholesterol level was demonstrated.

PREDIMED: Randomized controlled trial on effect of Mediterranean diet on metabolic syndrome

  • SOURCE and YEAR: Arch Intern Med. 2008[5]
  • STUDY NAME: PREDIMED (Prevención con Dieta Mediterránea)
  • OBJECTIVE: Determine the efficacy of the Mediterranean diet (Med-Diet) on the primary prevention of cardiovascular disease
  • METHOD: Multicenter, 3-arm randomized controlled trial.
  • STUDY POPULATION: 1224 participants
  • STUDY PERIOD: 1 year
  • INTERVENTIONS: Quarterly education about the MedDiet + provision of either 1 L/wk of virgin olive oil or 30 g/d of mixed nuts, and advice on a low-fat diet (control diet).
  • RESULTS:
    • 61.4% of participants met criteria for the metabolic syndrome
    • 1 yr prevalence was reduced by 6.7%, 13.7%, and 2.0% in the MedDiet + virgin olive oil, MedDiet + nuts, and control diet groups, respectively
    • After adjustment for sex, age, baseline obesity status, and weight changes odds ratios for reversion of metabolic syndrome were:
      • 1.3 (95% confidence interval, 0.8-2.1) for the MedDiet + virgin olive oil compared with control group.
      • 1.7 (1.1-2.6) for the MedDiet + nuts group compared with control group.
  • CONCLUSION: A Mediterranean diet can be helpful in the management of metabolic syndrome.

References

  1. Levesque J, Lamarche B (2008). "The metabolic syndrome: definitions, prevalence and management". Journal of Nutrigenetics and Nutrigenomics. 1 (3): 100–8. doi:10.1159/000112457. PMID 19776619.
  2. Cornier MA, Dabelea D, Hernandez TL; et al. (2008). "The metabolic syndrome". Endocrine Reviews. 29 (7): 777–822. doi:10.1210/er.2008-0024. PMID 18971485. Unknown parameter |month= ignored (help)
  3. Barnes DE (2011). "The mediterranean diet: good for the heart = good for the brain?". Ann Neurol. 69 (2): 226–8. doi:10.1002/ana.22376. PMID 21387364.
  4. 4.0 4.1 Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB (2011). "The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals". J Am Coll Cardiol. 57 (11): 1299–313. doi:10.1016/j.jacc.2010.09.073. PMID 21392646.
  5. 5.0 5.1 Salas-Salvadó J, Fernández-Ballart J, Ros E, Martínez-González MA, Fitó M, Estruch R; et al. (2008). "Effect of a Mediterranean diet supplemented with nuts on metabolic syndrome status: one-year results of the PREDIMED randomized trial". Arch Intern Med. 168 (22): 2449–58. doi:10.1001/archinte.168.22.2449. PMID 19064829.
  6. Azadbakht L, Mirmiran P, Esmaillzadeh A, Azizi T, Azizi F (2005). "Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome". Diabetes Care. 28 (12): 2823–31. PMID 16306540.
  7. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS; et al. (2003). "A randomized trial of a low-carbohydrate diet for obesity". N Engl J Med. 348 (21): 2082–90. doi:10.1056/NEJMoa022207. PMID 12761365.
  8. Stern L, Iqbal N, Seshadri P, Chicano KL, Daily DA, McGrory J; et al. (2004). "The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial". Ann Intern Med. 140 (10): 778–85. PMID 15148064.
  9. Meckling KA, Sherfey R (2007). "A randomized trial of a hypocaloric high-protein diet, with and without exercise, on weight loss, fitness, and markers of the Metabolic Syndrome in overweight and obese women". Appl Physiol Nutr Metab. 32 (4): 743–52. doi:10.1139/H07-059. PMID 17622289.
  10. Liu L, Wang Y, Lam KS, Xu A (2008). "Moderate wine consumption in the prevention of metabolic syndrome and its related medical complications". Endocr Metab Immune Disord Drug Targets. 8 (2): 89–98. PMID 18537695.
  11. Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E; et al. (2011). "Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis". BMJ. 343: d4488. doi:10.1136/bmj.d4488. PMC 3163382. PMID 21875885.

Template:WS Template:WH